You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 7, July 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Radiologic Imaging
 •Alzheimer Disease
 •Cognitive Disorders
 •Prognosis/ Outcomes
 •Neurology, Other
 •Magnetic Resonance Imaging
 •Alert me on articles by topic

Magnetic Resonance Imaging Predictors of Cognition in Mild Cognitive Impairment

Laura A. van de Pol, MD; Esther S. C. Korf, MD; Wiesje M. van der Flier, PhD; H. Robert Brashear, MD; Nick C. Fox, MD, FRCP; Frederik Barkhof, MD, PhD; Philip Scheltens, MD, PhD

Arch Neurol. 2007;64(7):1023-1028.

Objectives  To describe magnetic resonance imaging characteristics in a large sample of subjects with mild cognitive impairment (MCI) and to investigate associations between these characteristics and cognition.

Design  Cohort study.

Setting  Baseline data of a randomized, double-blind, placebo-controlled clinical trial of galantamine in MCI (Trial Registration: clinicaltrials.gov Identifier: NCT00236574).

Patients  Included in the study were 896 subjects with MCI (age [mean ± SD], 70 ± 9 years; 54% women) with available clinical and magnetic resonance imaging data.

Main Outcome Measures  Neuropsychology: Alzheimer Disease Assessment Scale, cognitive subscale, MCI version, assessing global cognition; delayed recall on the New York University Paragraph Recall Test, assessing episodic memory; and Digit Symbol Substitution Test, assessing executive function. Neuroimaging: Medial Temporal Lobe Atrophy (MTA) Rating Scale (0-4) and Age-Related White Matter Changes Scale (0-30), assessing white matter hyperintensities (WMHs); and lacune counts.

Results  Median MTA score was 2 (range, 0-4), and mean (± SD) Age-Related White Matter Changes Scale score 6.0 (± 4.7). Lacunes were present in 33% of subjects. In unadjusted models, increasing MTA and WMHs were associated with poorer performance on all cognitive tests, and lacunes with poorer performance on the Alzheimer Disease Assessment Scale, cognitive subscale, MCI version, and the Digit Symbol Substitution Test. In multivariable models, including magnetic resonance imaging measures simultaneously, MTA remained a predictor of cognition, whereas WMH had no independent predictive value. There was an interaction between MTA and lacunes: the strength of the association with the Digit Symbol Substitution Test increased with decreasing MTA.

Conclusions  Medial temporal lobe atrophy seems to be a more important predictor of cognition than small-vessel disease in MCI. Lacunes were associated with performance on the Digit Symbol Substitution Test, especially in subjects with milder MTA. Although WMHs were prevalent and associated with cognition in unadjusted analyses, there was no discernible association between WMHs and the cognitive measures in this study after adjustment for age.


Author Affiliations: Departments of Neurology (Drs van de Pol, Korf, van der Flier, Fox, and Scheltens) and Radiology, Image Analysis Centre (Dr Barkhof), Alzheimer Centre, VU Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Johnson & Johnson Pharmaceutical Research and Development, LLC, Raritan, New Jersey (Dr Brashear); and Dementia Research Centre, Institute of Neurology, University College London, London, United Kingdom (Dr Fox).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vascular Subcortical Hyperintensities Predict Conversion to Vascular and Mixed Dementia in MCI Patients
Bombois et al.
Stroke 2008;39:2046-2051.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.